KPTI
Karyopharm Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.88
+5.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.13x
- Price / sales
- 0.29x
- Price / cash flow
- -0.65x
Enterprise value
- Enterprise value
- $193.4M
- EV / sales
- 1.32x
- EV / EBITDA
- -1.10x
- EV / EBIT
- -2.35x
- Market cap
- $42.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026